Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
25.55
-0.32 (-1.24%)
Jun 29, 2026, 4:00 PM EDT - Market closed
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.61 billion as of June 30, 2026. Its market cap has increased by 240.62% in one year.
Market Cap
1.61B
Enterprise Value
1.16B
1-Year Change
240.62%
Ranking
Category
Stock Price
$25.55
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.61B, an increase of 138.45%. That is a compound annual growth rate of 62.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.61B | -17.24% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.69B |
| Mesoblast | 1.69B |
| Septerna | 1.68B |
| UroGen Pharma | 1.68B |
| Fortrea Holdings | 1.67B |
| MoonLake Immunotherapeutics | 1.64B |
| Aktis Oncology | 1.63B |
| Maravai LifeSciences Holdings | 1.61B |